Free Trial

Canvas Wealth Advisors LLC Cuts Stock Position in Henry Schein, Inc. $HSIC

Henry Schein logo with Medical background

Key Points

  • Canvas Wealth Advisors LLC significantly reduced its stake in Henry Schein, Inc. by 65.1%, selling over 7,000 shares during the second quarter, leaving them with a total of 3,938 shares valued at $277,000.
  • Multiple institutional investors have taken varying actions on Henry Schein, with JPMorgan Chase & Co. increasing its stake by 6.5% to own over 6.3 million shares.
  • Analysts have downgraded Henry Schein's stock, with the consensus rating now at "Hold" and a target price of $76.67, following recent reports indicating earnings missed expectations.
  • Five stocks to consider instead of Henry Schein.

Canvas Wealth Advisors LLC trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 65.1% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,938 shares of the company's stock after selling 7,356 shares during the period. Canvas Wealth Advisors LLC's holdings in Henry Schein were worth $277,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in the business. JPMorgan Chase & Co. lifted its stake in Henry Schein by 6.5% in the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company's stock worth $436,489,000 after purchasing an additional 390,399 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Henry Schein by 4.8% in the first quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company's stock worth $153,480,000 after purchasing an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. lifted its position in shares of Henry Schein by 33.9% in the first quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company's stock worth $153,105,000 after buying an additional 566,530 shares in the last quarter. Clarkston Capital Partners LLC lifted its position in shares of Henry Schein by 0.4% in the first quarter. Clarkston Capital Partners LLC now owns 1,751,570 shares of the company's stock worth $119,965,000 after buying an additional 7,345 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its stake in Henry Schein by 1.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,203,676 shares of the company's stock valued at $82,440,000 after buying an additional 11,999 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Stifel Nicolaus reaffirmed a "hold" rating and set a $75.00 price objective (down from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Wall Street Zen cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Saturday, October 11th. Robert W. Baird reiterated a "neutral" rating and set a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Barrington Research reissued an "outperform" rating and issued a $78.00 price objective on shares of Henry Schein in a research note on Tuesday, September 23rd. Finally, Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Five investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $76.67.

Check Out Our Latest Analysis on HSIC

Henry Schein Price Performance

HSIC stock opened at $63.93 on Tuesday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average price of $67.07 and a 200 day moving average price of $68.59. The stock has a market cap of $7.75 billion, a PE ratio of 20.62, a P/E/G ratio of 2.08 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm had revenue of $3.24 billion during the quarter, compared to analysts' expectations of $3.22 billion. During the same period last year, the company earned $1.23 earnings per share. The business's revenue for the quarter was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.